The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
The FDA's Assessment of Two Drugs for Chronic Weight Management
Abstract
After weighing the risks and benefits, the FDA recently approved two new drugs as adjuncts to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adults with at least one weight-related coexisting condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“No cancer-related safety issues arose during the 1-year trial involving more than 2400 lorcaserin-treated patients [16].”
From Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? (2021) · cites this paper as [16]
In the citing paper
“After the withdrawal of sibutramine in 2010, the FDA sought cardiovascular-safety data for new anti-obesity drugs [16].”
From Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? (2021) · cites this paper as [16]
Citations
Cites
Gadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60205-5 · Cited by 1,064
Multicenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911
Garvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., Schwiers, M., Day, W. W., & Bowden, C. H. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.024927 · Cited by 716
Allison, D. B., Gadde, K. M., Garvey, W. T., Peterson, C. A., Schwiers, M. L., Najarian, T., Tam, P. Y., Troupin, B., & Day, W. W. (2012) · Obesity · doi:10.1038/oby.2011.330 · Cited by 711
Fidler, M. C., Sanchez, M., Raether, B., Weissman, N. J., Smith, S. R., Shanahan, W. R., & Anderson, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1256 · Cited by 565
O'Neil, P. M., Smith, S. R., Weissman, N. J., Fidler, M. C., Sanchez, M., Zhang, J., Raether, B., Anderson, C. M., & Shanahan, W. R. (2012) · Obesity · doi:10.1038/oby.2012.66 · Cited by 525
The Obesity Epidemic and Its Impact on Hypertension
Nguyen, T., & Lau, D. C. W. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.01.001 · Cited by 223
Use of topiramate in pregnancy and risk of oral clefts
Margulis, A. V., Mitchell, A. A., Gilboa, S. M., Werler, M. M., Mittleman, M. A., Glynn, R. J., & Hernández–Dı́az, S. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.07.008 · Cited by 178
Serotonergic drugs and valvular heart disease
Rothman, R. B., & Baumann, M. H. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330902931524 · Cited by 144
Obesity and type 2 diabetes: which patients are at risk?
Garber, A. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01536.x · Cited by 114
Hendricks, E. J., Greenway, F. L., Westman, E. C., & Gupta, A. K. (2011) · Obesity · doi:10.1038/oby.2011.94 · Cited by 97
Díaz, E. G., & Folgueras, T. M. (2011) · PubMed · doi:10.1590/s0212-16112011000300004 · Cited by 23
Withdrawal of Sibutramine for Weight Loss: Where Does This Leave Clinicians?
Czernichow, S., & Batty, G. D. (2010) · Obesity Facts · doi:10.1159/000316508 · Cited by 20
Flagged first, then by citations
Cited by
Sorted by citations
Long-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak, Y. J., & Lee, S. Y. (2021) · Current Obesity Reports · doi:10.1007/s13679-020-00422-w · Cited by 343
Phentermine and topiramate for the management of obesity: a review
Uwaifo, G. I., Cosentino, & Conrad, A. O. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s31443 · Cited by 242
Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis
Berglund, E. D., Liu, C., Sohn, J., Liu, T., Kim, M. H., Lee, C. E., Vianna, C. R., Williams, K. W., Xu, Y., & Elmquist, J. K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70338 · Cited by 232
Locally Induced Adipose Tissue Browning by Microneedle Patch for Obesity Treatment
Zhang, Y., Liu, Q., Yu, J., Yu, S., Wang, J., Qiang, L., & Gu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b04348 · Cited by 229
Metadata
- Authors
- Colman, E., Golden, J., Roberts, M., Egan, A., Weaver, J., & Rosebraugh, C.
- Affiliations
- United States Food and Drug Administration (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-10-25
- Volume
- 367
- Issue
- 17
- Pages
- 1577-1579
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331430051
- Cited by
- 342
- References
- 13
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 14 · 2020: 162 · 2019: 11 · 2018: 7 · 2017: 17 · 2016: 18 · 2015: 22 · 2014: 24 · 2013: 42 · 2012: 3
- FWCI
- 21.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- chronic weight management, obesity, overweight adults, FDA drug approval, anti-obesity drugs, adjunctive therapy, hypocaloric diet, physical activity, comorbidities, risk-benefit assessment
- MeSH terms
- Abnormalities, Drug-Induced, Topiramate, Benzazepines, Delayed-Action Preparations, Drug Combinations, Female, Fructose, Humans, Obesity, Phentermine, Pregnancy, United States, United States Food and Drug Administration, Weight Loss, Drug Approval, Serotonin Receptor Agonists, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
